Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States.

Publication Title

Kidney Med

Document Type

Article

Publication Date

1-1-2023

Keywords

washington; spokane; pmrc

Clinical Institute

Kidney & Diabetes

Specialty

Nephrology

Specialty

Endocrinology

DOI

10.1016/j.xkme.2022.100590

Share

COinS